The concept that most ovarian malignancies are not derived from the surface epithelium of the ovary itself may have major implications for clinical practice. It will change the way we might think about screening and preventing the disease from occurring in the first place. This is the first article in this new clinic on women’s health.
Ovarian cancer remains the most lethal of all gynaecological cancers, with more than 800 women annually in Australia dying from the disease despite major improvements in the surgical approach and cytotoxic drug treatment. These improvements have together resulted in longer survival of patients with the disease but unfortunately have not impacted on the overall cure rate.